BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 34143331)

  • 21. Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid.
    Hougardy BM; van der Zee AG; van den Heuvel FA; Timmer T; de Vries EG; de Jong S
    Gynecol Oncol; 2005 May; 97(2):353-64. PubMed ID: 15863130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sildenafil Inhibits the Growth and Epithelial-to-mesenchymal Transition of Cervical Cancer via the TGF-β1/Smad2/3 Pathway.
    Liu P; Pei JJ; Li L; Li JW; Ke XP
    Curr Cancer Drug Targets; 2023; 23(2):145-158. PubMed ID: 35975844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cervical Cancer Cell Growth, Drug Resistance, and Epithelial-Mesenchymal Transition Are Suppressed by y-Secretase Inhibitor RO4929097.
    Wang L; Dai G; Yang J; Wu W; Zhang W
    Med Sci Monit; 2018 Jun; 24():4046-4053. PubMed ID: 29899322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knockdown of BRCC3 exerts an anti‑tumor effect on cervical cancer in vitro.
    Zhang F; Zhou Q
    Mol Med Rep; 2018 Dec; 18(6):4886-4894. PubMed ID: 30272359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Effects Of Sevoflurane On The Progression And Cisplatinum Sensitivity Of Cervical Cancer Cells.
    Xue F; Xu Y; Song Y; Zhang W; Li R; Zhu X
    Drug Des Devel Ther; 2019; 13():3919-3928. PubMed ID: 31819366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of hsa-miR-6727-5p on the proliferation, apoptosis, invasion and migration of Caski, Hela and SiHa cervical cancer cells.
    Liu H; Pei G; Song M; Dai S; Wang Y
    J BUON; 2017; 22(4):973-978. PubMed ID: 28952216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SATB1 Knockdown Inhibits Proliferation and Invasion and Decreases Chemoradiation Resistance in Nasopharyngeal Carcinoma Cells by Reversing EMT and Suppressing MMP-9.
    Zhou D; Ye C; Pan Z; Deng Y
    Int J Med Sci; 2021; 18(1):42-52. PubMed ID: 33390772
    [No Abstract]   [Full Text] [Related]  

  • 28. miR‑519d‑3p/HIF‑2α axis increases the chemosensitivity of human cervical cancer cells to cisplatin via inactivation of PI3K/AKT signaling.
    Jiang L; Shi S; Li F; Shi Q; Zhong T; Zhang H; Xia Y
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. KLF5 inhibits the migration and invasion in cervical cancer cell lines by regulating SNAI1.
    Qu X; Xu C; Yang W; Li Q; Tu S; Gao C
    Cancer Biomark; 2024; 39(3):231-243. PubMed ID: 38217587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Berberine modulates Keratin 17 to inhibit cervical cancer cell viability and metastasis.
    Liu L; Sun L; Zheng J; Cui L
    J Recept Signal Transduct Res; 2021 Dec; 41(6):521-531. PubMed ID: 33045871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KRT17 confers paclitaxel-induced resistance and migration to cervical cancer cells.
    Li J; Chen Q; Deng Z; Chen X; Liu H; Tao Y; Wang X; Lin S; Liu N
    Life Sci; 2019 May; 224():255-262. PubMed ID: 30928404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [EBF1 Promotes the Sensitivity of Cervical Cancer Cells to Cisplatin via Activating FBN1 Transcription].
    Shen NN; Lin JH; Liu PP
    Mol Biol (Mosk); 2023; 57(3):503-504. PubMed ID: 37326054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-181a Promotes Apoptosis and Reduces Cisplatin Resistance by Inhibiting Osteopontin in Cervical Cancer Cells.
    Xu X; Jiang X; Chen L; Zhao Y; Huang Z; Zhou H; Shi M
    Cancer Biother Radiopharm; 2019 Nov; 34(9):559-565. PubMed ID: 31436472
    [No Abstract]   [Full Text] [Related]  

  • 34. MicroRNA-106a-5p alleviated the resistance of cisplatin in lung cancer cells by targeting Jumonji domain containing 6.
    Ge X; Jiang Y; Hu X; Yu X
    Transpl Immunol; 2021 Dec; 69():101478. PubMed ID: 34607003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Silencing MTA1 by RNAi reverses adhesion, migration and invasiveness of cervical cancer cells (SiHa) via altered expression of p53, and E-cadherin/β-catenin complex.
    Rao Y; Wang H; Fan L; Chen G
    J Huazhong Univ Sci Technolog Med Sci; 2011 Feb; 31(1):1-9. PubMed ID: 21336715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppressing effects of green tea extract and Epigallocatechin-3-gallate (EGCG) on TGF-β- induced Epithelial-to-mesenchymal transition via ROS/Smad signaling in human cervical cancer cells.
    Panji M; Behmard V; Zare Z; Malekpour M; Nejadbiglari H; Yavari S; Nayerpour Dizaj T; Safaeian A; Maleki N; Abbasi M; Abazari O; Shabanzadeh M; Khanicheragh P
    Gene; 2021 Aug; 794():145774. PubMed ID: 34126197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells.
    Cheng KY; Hao M
    Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TIM-1 promotes proliferation and metastasis, and inhibits apoptosis, in cervical cancer through the PI3K/AKT/p53 pathway.
    Chen L; Qing J; Xiao Y; Huang X; Chi Y; Chen Z
    BMC Cancer; 2022 Apr; 22(1):370. PubMed ID: 35392845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Vasohibin-2 promotes proliferation and metastasis of cervical cancer cells by regulating epithelial-mesenchymal transition].
    Wang J; Yu C; Jiang X; Wu X; Jia Y; Zhang H; Li Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jul; 42(7):966-975. PubMed ID: 35869758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circular RNA hsa_circ_0096157 contributes to cisplatin resistance by proliferation, cell cycle progression, and suppressing apoptosis of non-small-cell lung carcinoma cells.
    Lu H; Xie X; Wang K; Chen Q; Cai S; Liu D; Luo J; Kong J
    Mol Cell Biochem; 2020 Dec; 475(1-2):63-77. PubMed ID: 32767026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.